← Leaderboards
Alyssa A Lebel
Boston Children'S Hospital
$1,070,016
Attributed
$2,140,031
Total exposure
1
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $539.6K · FY2022–25$1M$750K$500K$250K$0
'22
'23
'24
'25
Funding mix
By agency
NIH$2,140,031 · 1
By mechanism
R01$2,140,031 · 1
Top collaborators
- Scott Holmes4 shared
Most similar at Boston Children'S Hospital
Same institution · by research overlap
- Laura E Simons$16,048,056
- Scott Holmes$2,281,047
- Timothy A Miller$5,553,429
- Hao Wu$9,538,132
Others in their field
Other Rising Stars on “Cohort”
- Gary Mays · Axle Informatics, Llc$58,129,860
- Brian Zavertnik · Palantir Technologies, Inc.$37,240,166
- Joan Grand · Mitre Corporation$32,826,287
- Bridget Murphy · Broad Institute, Inc.$23,600,775
- Suma Babu · Massachusetts General Hospital$22,928,184
- Sabrina Paganoni · Massachusetts General Hospital$22,928,184
Research focus
CohortComplexAdolescentAbsence Of Pain SensationAdultBiobehaviorBiopsychosocialBrainBrain ConcussionBrain RegionBehavioralCentral PainCharacteristicsChildChildhoodChronicChronic Daily HeadachesChronic HeadachesChronic PainChronic Painful ConditionClassificationClinical CareClinically RelevantCovid-19
Grant awards (4)
Pediatric Chronic Headache and COVID-19: Use of Machine Learning and Biobehavioral Analysis to Classify Headache Mechanism and Optimize Treatment Course.$539,602
R01 · FY2025 · NS
Pediatric Chronic Headache and COVID-19: Use of Machine Learning and Biobehavioral Analysis to Classify Headache Mechanism and Optimize Treatment Course.$523,414
R01 · FY2024 · NS
Pediatric Chronic Headache and COVID-19: Use of Machine Learning and Biobehavioral Analysis to Classify Headache Mechanism and Optimize Treatment Course.$539,602
R01 · FY2023 · NS
Pediatric Chronic Headache and COVID-19: Use of Machine Learning and Biobehavioral Analysis to Classify Headache Mechanism and Optimize Treatment Course.$537,413
R01 · FY2022 · NS